Mounjaro Wegovy GLP-1 Agonist Pancreatic Cancer Risk? Side Effects.

2 Views

07/30/23

There are quite a few side effects from the class of medication call GLP-1 agonist. Two of the most common or most well-known brand names for this class of medication. number one Mounjaro and number 2 Wegovy. The common side effects of these medications could include nausea, vomiting, constipation, bloating, mild , abdominal pain Hypoglycemia. There has been also reported increased risk for medullary thyroid cancer as well as see C-cell thyroid type of cancer as well as multiple endocrine neoplasia type 2. Multiple endocrine neoplasia type two cancer as well. Therefore the FDA put a black box warning for this class of medication. Ultimately, there has been the question of whether this class of drugs caused pancreatic cancer or not And it has been raised on many occasions over the last decade or so. There are many studies looking into this involving hundreds of thousands of patients and so far the consensus from all these studies did not suggest any direct or indirect link of pancreatic cancer to this class of medication, namely Mounjaro or Wegovy. However, there are still concerns and there is a study in Europe right now looking at over 600,000 people and more data as a to be coming in the next two years.